Table 3 Spearman correlation of EL plasma levels with plasma lipids and lipoproteins.

From: Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients

 

no-MetS

MetS

rho

p-value

rho

p-value

Total cholesterol (mmol/L)

0.46

<0.001

0.19

0.090

LDL-cholesterol (mmol/L)

0.38

0.002

0.16

0.153

HDL-cholesterol (mmol/L)

0.45

<0.001

−0.11

0.318

Triglycerides (mmol/L)

0.30

0.013

0.29

0.007

LVLDL-p (nmol/L)

0.21

0.272

0.12

0.430

TLDL-p (nmol/L)

0.28

0.029

0.16

0.161

LLDL-p (mmol/L)

0.24

0.071

−0.02

0.857

SLDL-p (nmol/L)

0.06

0.650

0.24

0.042

THDL-p (nmol/L)

0.47

<0.001

0.17

0.153

LHDL-p (nmol/L)

0.13

0.348

−0.38

0.004

SHDL-p (nmol/L)

0.34

0.019

0.22

0.076

VLDL-s (nm)

0.14

0.286

−0.12

0.304

LDL-s (nm)

0.10

0.457

−0.24

0.036

HDL-s (nm)

−0.12

0.352

−0.32

0.006

  1. HDL-high density lipoprotein; LDL-low-density lipoprotein; LVLDL-p –large very low-density lipoprotein particle; TLDL-p –total LDL particles; LLDL-p –large LDL particles; SLDL-p –small LDL-p; THDL-p –total HDL-particles; LHDL-p –large HDL-p; SHDL-p –small HDL-p; VLDL-s –VLDL size; LDL-s –LDL size; HDL-s –HDL size. Significant associations are depicted in bold.